Insider Transactions in Q4 2023 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2023
|
Rebecca Chambers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,800
-1.94%
|
$46,800
$26.54 P/Share
|
|
Dec 02
2023
|
John Leite Chief Commercial Officer-CLIA |
SELL
Payment of exercise price or tax liability
|
Direct |
556
-1.42%
|
$14,456
$26.54 P/Share
|
|
Dec 02
2023
|
Marc Stapley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,203
-1.42%
|
$83,278
$26.54 P/Share
|
|
Dec 02
2023
|
Jonathan Wygant VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
507
-1.84%
|
$13,182
$26.54 P/Share
|
|
Dec 02
2023
|
Annie Mc Guire SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
803
-1.53%
|
$20,878
$26.54 P/Share
|
|
Oct 02
2023
|
Phillip G. Febbo Chief Scientific & Med Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,182
+50.0%
|
-
|